Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Sales: 2012-2025

Historic Return on Sales for Sunshine Biopharma (SBFM) over the last 12 years, with Sep 2025 value amounting to -0.16%.

  • Sunshine Biopharma's Return on Sales fell 3.00% to -0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.16%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of -0.15% for FY2024, which is 4.00% up from last year.
  • Per Sunshine Biopharma's latest filing, its Return on Sales stood at -0.16% for Q3 2025, which was up 7.48% from -0.17% recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Return on Sales registered a high of -0.12% during Q2 2024, and its lowest value of -88.43% during Q1 2021.
  • Moreover, its 3-year median value for Return on Sales was -0.16% (2025), whereas its average is -0.67%.
  • In the last 5 years, Sunshine Biopharma's Return on Sales crashed by 6,723bps in 2021 and then surged by 7,759bps in 2022.
  • Sunshine Biopharma's Return on Sales (Quarterly) stood at -54.44% in 2021, then spiked by 4,829bps to -6.15% in 2022, then soared by 597bps to -0.19% in 2023, then grew by 4bps to -0.15% in 2024, then fell by 3bps to -0.16% in 2025.
  • Its last three reported values are -0.16% in Q3 2025, -0.17% for Q2 2025, and -0.14% during Q1 2025.